We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

115 hedge funds and large institutions have $200M invested in TG Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more call options, than puts

Call options by funds: $4.51M | Put options by funds: $2.2M

59% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 27

1.42% more ownership

Funds ownership: 57.56% → 58.98% (+1.4%)

9% less funds holding

Funds holding: 127 → 115 (-12)

25% less capital invested

Capital invested by funds: $267M → $200M (-$66.5M)

41% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 27

Holders
115
Holders Change
-12
Holders Change %
-9.45%
% of All Funds
2.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
43
Reduced
27
Closed
27
Calls
$4.51M
Puts
$2.2M
Net Calls
+$2.3M
Net Calls Change
+$4.13M

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$7.96M
2
GPP
Great Point Partners
Connecticut
+$5.22M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.9M
4
ACA
Avoro Capital Advisors
New York
+$2.73M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$10.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$5.36M
3
Bank of America
Bank of America
North Carolina
-$2.9M
4
NC
Nexthera Capital
New York
-$2.49M
5
HCMT
Highland Capital Management (Texas)
Texas
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
26
Raymond James & Associates
Florida
$1.35M +$479K +96,385 +41%
JP Morgan Chase
27
JP Morgan Chase
New York
$1.18M -$83.4K -16,779 -6%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.14M -$42.5K -8,549 -3%
Citadel Advisors
29
Citadel Advisors
Florida
$770K -$1.09M -220,158 -54%
CCI
30
Columbus Circle Investors
$679K -$377K -75,891 -31%
Assenagon Asset Management
31
Assenagon Asset Management
Luxembourg
$642K +$779K +156,700 New
Group One Trading
32
Group One Trading
Illinois
$599K +$1.93K +389 +0.3%
RJFSA
33
Raymond James Financial Services Advisors
Florida
$588K -$11.2K -2,255 -2%
TA
34
Teachers Advisors
New York
$584K +$74.9K +15,069 +12%
ARTA
35
A.R.T. Advisors
New York
$563K +$549K +110,382 +412%
AllianceBernstein
36
AllianceBernstein
Tennessee
$503K +$199K +40,100 +49%
Millennium Management
37
Millennium Management
New York
$490K -$804K -161,704 -57%
Swiss National Bank
38
Swiss National Bank
Switzerland
$481K +$41.2K +8,300 +8%
TCIM
39
TIAA CREF Investment Management
New York
$461K – – –
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$403K +$11.4K +2,285 +2%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$396K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$323K +$134K +26,880 +52%
Wells Fargo
43
Wells Fargo
California
$313K +$160K +32,254 +73%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$300K +$291K +58,573 +406%
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$292K +$33.9K +6,812 +11%
Wolverine Trading
46
Wolverine Trading
Illinois
$291K +$126K +25,295 +53%
UCFA
47
United Capital Financial Advisors
Texas
$279K +$234K +47,000 +223%
EP
48
Eversept Partners
New York
$267K – – –
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$266K +$22.4K +4,500 +7%
VEA
50
Virtus ETF Advisers
New York
$252K +$135K +27,134 +79%
1
2
3 4 5

TGTX Hedge Fund Activity: Q4 2018 in Review

115 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q4 2018, worth a combined $200M — down 25% from $267M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of TGTX and 16 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 43 added.

The largest buyer was Bridger Management, adding an estimated $7.96M. The largest seller was Franklin Resources, exiting entirely with an estimated $10.6M sold.

  • 115 institutional investors held TG Therapeutics (TGTX) as of Q4 2018, down from 127 in Q3 2018.
  • Funds reported $200M of TG Therapeutics stock for Q4 2018, down 25% quarter-over-quarter.
  • 16 funds opened new TG Therapeutics positions in Q4 2018 and 27 closed out, a net change of -11 holders.
  • The largest TG Therapeutics buyer in Q4 2018 was Bridger Management, an estimated $7.96M added.
  • The largest TG Therapeutics seller in Q4 2018 was Franklin Resources, an estimated $10.6M sold.

Based on aggregated 13F filings for Q4 2018.